National Chemotherapy Advisory Group report: implications for nurses
Elaine Lennan Vice-chair, UKONS Chemotherapy Nurses Forum, Southampton University Hospitals NHS Trust, Southampton
Helen Roe Chair, UKONS Chemotherapy Nurses Forum, North Cumbria University Hospitals NHS Trust, North Cumbria
Annie Young Former UKONS president, and acting director, 3 Counties Cancer Network, Gloucester
Maggie Crowe UKONS president, and development manager, Macmillan Cancer Support, Crown Chambers, Hampshire
As a group of senior cancer nurses, the UK Oncology Nursing Society (UKONS) Board welcomes the recommendations from the National Chemotherapy Advisory Group report, believing that it will improve the services offered to patients and strengthen the leadership role of nurses who work in cancer care. This article explains the key tenets of the report from a nursing perspective and considers the effect it will have on chemotherapy services and on the profession as a whole.
Nursing Standard.
24, 36, 35-40.
doi: 10.7748/ns2010.05.24.36.35.c7773
Correspondence
elaine.lennan@suht.swest.nhs.uk
Peer review
This article has been subject to double blind peer review
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
